Skip to main content

Colloidal Silver

Common Name(s): Argent colloidal, Colloidal silver, Colloidal silver protein, Plata coloidal, Protéine d’argent, Silver colloid

Medically reviewed by Last updated on Apr 21, 2023.

Clinical Overview


Colloidal silver has been investigated for use in wound healing and prevention of wound infection. Despite several purported uses, clinical trial data are lacking to recommend use for any indication, and the US Food and Drug Administration (FDA) has ruled that colloidal silver or silver salts for internal or external use are "not generally recognized as safe and effective and are misbranded."


Insufficient evidence exists to provide dosing recommendations for colloidal silver.


None documented.


Avoid use. Silver may cross the placenta.


None well documented.

Adverse Reactions

Oral ingestion of silver salts may cause GI irritation. GI bleeding, seizures, and skin discoloration reported in the literature are primarily due to silver toxicity (see Toxicology).


Argyria (purple-grey colored skin) is a recognized adverse outcome of exposure to colloidal silver. Hematological and neurological toxicities are rare but well documented.


Sliver is a metallic element (chemical symbol: Ag) with an atomic number of 47 and an atomic mass of 107.868 g/mol. Silver ions are dissociated from different salts and from particulate silver. Sliver nanoparticulate suspensions are typically mixtures consisting of silver ions, nanoparticles, subnano-sized particles, and aggregated nanosized or larger nanoparticles.Hadrup 2014 Colloidal silver is a suspension of submicroscopic metallic silver particles in a colloidal base, which results in an overall increased particle surface area.Franco-Molina 2010, CFR 1999


Dating from the Middle Ages, silver as the nitrate form ("lunar caustic") was used for the treatment of nervous disorders and epilepsy. Silver arsphenamine was used for treating syphilis.Fung 1996 Antibacterial activity of silver, reportedly described in ancient Greek texts, has resulted in widespread applications such as in prostheses, catheters, dental materials and textile fabrics, and in the management of skin and other infections.Fung 1996, Panacek 2006

Colloidal silver products are available as homeopathic remedies and dietary supplements. Purported uses include cancer, diabetes, arthritis, and many others. Colloidal silver preparations were formerly included in pharmaceutical texts (ie, prior to 1975); however, in 1999, the FDA ruled that colloidal silver or silver salts for internal or external use are "not generally recognized as safe and effective and are misbranded."CFR 1999

Colloidal silver generators are commercially available, and instructional videos demonstrating how to manufacture colloidal silver products at home are available via the internet. The basic premise is the use of electricity to reduce silver rods to the ionic form and suspend them in a liquid solution.Okan 2007


Colloidal silver consists of submicroscopic metallic silver particles suspended in a colloid base. Colloidal silver preparations contain silver ion concentrations of about 1 to 6 ppm (5 to 30 mcg) per dose; however, methods of production and silver content of marketed products can be highly variable.Fung 1996, Okan 2007, CFR 1999

Colloidal silver proteins are prepared by mixing silver nitrate, sodium hydroxide, and gelatin. The resulting mixture is diluted with water to achieve the desired concentration.Fung 1996 Techniques for synthesizing silver nanomaterials have been described.Panacek 2006, Tolaymat 2010

Uses and Pharmacology

Silver is considered nonessential to human physiology.Hadrup 2014 Limited clinical studies to determine a role for colloidal silver have been conducted; however, inconsistencies in the products used (ie, in silver particle size and content) exist.Duval 2019, CFR 1999

Silver binds to reactive groups of proteins, denaturing the protein (including enzymes such as lactate dehydrogenase and glutathione peroxidase) and causing precipitation. Silver has been noted to bind to sulfhydryl, amino, carboxyl, phosphate, and imidazole groups.Fung 1996, Tolaymat 2010


In vitro data

Limited in vitro studies suggest colloidal silver may reduce oxidative stress and induce apoptosis in human cancer cell lines.Franco-Molina 2010, Kim 2007, Lamb 2010 Conversely, a possible mechanism of silver colloidal solutions is the formation of intracellular free radicals.Duval 2019

Clinical data

Clinical studies evaluating colloidal silver for prevention or treatment of cancer are lacking. No evidence exists to support claims that silver deficiency is linked to impaired immunity and thereby a risk factor for cancer.Fung 1996

Infections/Wound healing

Animal and in vitro data

In vitro antibacterial and antifungal properties of colloidal silver have been reported.Panacek 2006, Petica 2008 Bactericidal effects of colloidal silver are considered to be inversely related to particle size (ie, smaller size having a greater antimicrobial effect) and may be related to influences on bacterial cell membrane or cell wall permeability, formation of free radicals, or alteration of the bacterial DNA replication process.Duval 2019, Panacek 2006, Tolaymat 2010

Colloidal silver irrigation has been evaluated in a chronic rhinosinusitis sheep model. Treatment with silver resulted in a significant decrease in Staphylococcus aureus biofilm biomass and in antibiofilm activity compared with saline control.Al-Asousi 2017 An in vitro study reported similar findings.Goggin 2014

Clinical data

Quality clinical studies evaluating the effects of oral colloidal silver in the prevention or treatment of infections are lacking.

In a randomized, crossover, controlled trial of patients with recalcitrant chronic rhinosinusitis (N=22), colloidal silver nasal spray did not demonstrate clinically meaningful subjective or objective improvements versus control.Scott 2017 Case series (N=5) demonstrate that applications of nano–colloidal silver in conjunction with chitosan bioactive as primary dressings in managing diabetic foot ulcers are safe and help increase wound healing rates; patients had slow healing rates at presentation.Nair 2018

Reviews of silver dressings and the role of silver nanoparticles in wound healing have been published.Okan 2007, Paladini 2019, Sterling 2014 A 2010 Cochrane review and meta-analysis found insufficient evidence to determine whether silver-containing dressings or topical agents promote wound healing or prevent wound infection.Storm-Versloot 2010


Insufficient evidence exists to provide dosing recommendations for colloidal silver.CFR 1999

Absorption of silver from the GI tract is estimated to be around 10%; excretion is very limited and occurs primarily via the biliary route.Fung 1996, Sterling 2014 Colloidal silver preparations have silver ion concentrations of about 1 to 6 ppm (5 to 30 mcg) per dose; however, methods of production and silver content of marketed products can be highly variable.Fung 1996, CFR 1999 Mild silver protein preparations contain 19% to 23% silver, while strong silver protein preparations contain 7.5% to 8.5% silver.Fung 1996

Pregnancy / Lactation

Avoid use. Silver may cross the placenta. Based on epidemiological studies, increased levels of silver in pregnant women have been reportedly linked to fetal abnormalities.Fung 1996


Case reports are lacking. In a prospective, single-blind, controlled, in vivo human study, no clinically important CYP-450 enzyme inhibition or induction activity was observed after oral ingestion of a commercial colloidal silver product over 14 days.(Munger 2015) However, an in vitro study evaluating cell viability reported that nanosilver may inhibit human microsomal CYP-450 activities, particularly CYP2C9, 2C19, and 3A4.(Lamb 2010)

Adverse Reactions

Limited studies have reported equivocal findings with respect to the effect of oral silver on platelet aggregation. In vitro studies report enhanced platelet aggregation, while a study in healthy volunteers found no effect with daily consumption of colloidal silver for 2 weeks.Smock 2014

Oral ingestion of silver salts may cause GI irritation, and reports of hemorrhage and death exist in the literature.Fung 1996 Intravenous colloidal silver infusions are more toxic and are not supported by any clinical evidence (see Toxicology).Natelson 2019

The use of silver (as vitellinate or nitrate) for the treatment of conjunctivitis frequently causes chemical irritation.Silva 2008


Animal studies suggest that consumption of silver at low concentrations for up to 40 days may be safe.CFR 1999 Studies suggest low genotoxicity.Hadrup 2014

Approximately 2% to 4% of silver absorbed from the GI tract is distributed to the skin and many other tissues (primarily in the GI tract, liver, spleen, and adrenals, with lesser amounts in the testes, muscle, and brain).Fung 1996, Hadrup 2014, Sterling 2014 Argyria, purple or purple-grey discoloration of the skin induced by silver, was reportedly first recognized in medical literature in 1791.Beutler 2016 Deposition of silver in the deeper epidermal and dermal layers of skin, and the resultant argyria, is permanent.Okan 2007

Hematological aberrations, including anemia, leukopenia, and neutropenia, have been described consequent to IV colloidal silver infusions. Apheresis and oral copper administration is suggested as a therapeutic option to address silver-induced anemia.Natelson 2019 Studies in rats report increased hematocrit, hemoglobin, and blood urea nitrogen values.Hadrup 2014

Neurological toxicity has been described, with silver possibly disrupting the blood-brain barrier.Fung 1996, Hadrup 2014, Naddaf 2019 A case report exists of fatal de novo myoclonic status epilepticus linked to consumption of colloidal silver for 4 months in an elderly man; silver accumulation in the brain was documented on autopsy.Mirsattari 2004 Another report of myoclonic seizures in a 75-year-old man describes a progressive neurodegenerative disorder related to consumption of colloidal silver over 4 years.Stepien 2009

Other reported manifestations of silver toxicity include toxic optic neuropathy, loss of optic choroidal signal, glomerular damage, proteinuria, and leukocytoclastic vasculitis.Docherty 2019, Fung 1996, Mohan 2019, Newlands 2018 Limited evidence suggests increased toxicity from silver may result from vitamin E or selenium deficiency.Fung 1996, Stepien 2009



This information relates to an herbal, vitamin, mineral or other dietary supplement. This product has not been reviewed by the FDA to determine whether it is safe or effective and is not subject to the quality standards and safety information collection standards that are applicable to most prescription drugs. This information should not be used to decide whether or not to take this product. This information does not endorse this product as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this product. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this product. This information is not specific medical advice and does not replace information you receive from your health care provider. You should talk with your health care provider for complete information about the risks and benefits of using this product.

This product may adversely interact with certain health and medical conditions, other prescription and over-the-counter drugs, foods, or other dietary supplements. This product may be unsafe when used before surgery or other medical procedures. It is important to fully inform your doctor about the herbal, vitamins, mineral or any other supplements you are taking before any kind of surgery or medical procedure. With the exception of certain products that are generally recognized as safe in normal quantities, including use of folic acid and prenatal vitamins during pregnancy, this product has not been sufficiently studied to determine whether it is safe to use during pregnancy or nursing or by persons younger than 2 years of age.

Al-Asousi F, Dadgostar A, Javer A. Sinonasal methicillin-resistant Staphylococcus aureus: updates on treatment. Curr Opin Otolaryngol Head Neck Surg. 2017;25(1):19-23.27841769
Beutler BD, Lee RA, Cohen PR. Localized cutaneous argyria: Report of two patients and literature review. Dermatol Online J. 2016;22(11).28329568
Docherty G, Martens R, Kirker A. Colloidal silver toxicity with absence of choroidal signal on optical coherence tomography. Can J Ophthalmol. 2019;54(4):e203-e205.31358171
Duval RE, Gouyau J, Lamouroux E. Limitations of recent studies dealing with the antibacterial properties of silver nanoparticles: Fact and opinion. Nanomaterials (Basel). 2019;9(12).31847133
Franco-Molina MA, Mendoza-Gamboa E, Sierra-Rivera CA, et al. Antitumor activity of colloidal silver on MCF-7 human breast cancer cells. J Exp Clin Cancer Res. 2010;29:148.21080962
Fung MC, Bowen DL. Silver products for medical indications: risk-benefit assessment. J Toxicol Clin Toxicol. 1996;34(1):119-126.8632503
Goggin R, Jardeleza C, Wormald PJ, Vreugde S. Colloidal silver: a novel treatment for Staphylococcus aureus biofilms? Int Forum Allergy Rhinol. 2014;4(3):171-175.24431107
Hadrup N, Lam HR. Oral toxicity of silver ions, silver nanoparticles and colloidal silver--a review. Regul Toxicol Pharmacol. 2014;68(1):1-7.24231525
Kim D, Hong GH, Lee HH, et al. Effect of colloidal silver against the cytotoxicity of hydrogen peroxide and naphthazarin on primary cultured cortical astrocytes. Int J Neurosci. 2007;117(3):387-400.17365122
Lamb JG, Hathaway LB, Munger MA, Raucy JL, Franklin MR. Nanosilver particle effects on drug metabolism in vitro. Drug Metab Dispos. 2010;38(12):2246-2251.20861156
Mirsattari SM, Hammond RR, Sharpe MD, Leung FY, Young GB. Myoclonic status epilepticus following repeated oral ingestion of colloidal silver. Neurology. 2004;62(8):1408-1410.15111684
Mohan N, Gomez C, Khawar N, Narula P, John M. Colloidal silver ingestion associated with leukocytoclastic vasculitis in an adolescent female. Am J Case Rep. 2019;20:730-734.31118408
Munger MA, Hadlock G, Stoddard G, et al. Assessing orally bioavailable commercial silver nanoparticle product on human cytochrome P450 enzyme activity. Nanotoxicology. 2015;9(4):474-481.25137296
Naddaf E, Dyck PJ, Jannetto PJ, Murray DL, Dyck PJB. Peripheral neuropathy associated with silver toxicity. Neurology. 2019;92(10):481-483.30709965
Nair HKR. Nano-colloidal silver and chitosan bioactive wound dressings in managing diabetic foot ulcers: case series. J Wound Care. 2018;27(suppl)(9a):S32-S36.30207850
Natelson EA, Baker KR, Pyatt DW. Anemia and leukopenia following intravenous colloidal silver infusions-Clinical and hematological features, unique peripheral blood film appearance and effective therapy with supplemental oral copper and apheresis. Clin Case Rep. 2019;7(9):1757-1762.31534743
Newlands SJ, Betts TD, Stack RR. Colloidal silver optic neuropathy. N Z Med J. 2018;131(1483):63-65.30286067
Okan D, Woo K, Sibbald RG. So what if you are blue? Oral colloidal silver and argyria are out: safe dressings are in. Adv Skin Wound Care. 2007;20(6):326-330.17538258
Paladini F, Pollini M. Antimicrobial silver nanoparticles for wound healing application: Progress and future trends. Materials (Basel). 2019;12(16).
Panacek A, Kvítek L, Prucek R, et al. Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J Phys Chem B. 2006;110(33):16248-16253.16913750
Petica A, Gavriliu S, Lungu M, et al. Colloidal silver solutions with antimicrobial properties. Materials Science and Engineering: B. 2008;152(1-3):22-27.
Rules and regulations: over-the-counter drug products containing colloidal silver ingredients or silver salts. 21 CFR §210. Fed Regist. 1999;64(158):44653-44658. Published August 17, 1999. Accessed March 27, 2020.
Scott JR, Krishnan R, Rotenberg BW, Sowerby LJ. The effectiveness of topical colloidal silver in recalcitrant chronic rhinosinusitis: a randomized crossover control trial. J Otolaryngol Head Neck Surg. 2017;46(1):64.29178954
Silva LR, Gurgel RQ, Lima DR, Cuevas LE. Current usefulness of Credé's method of preventing neonatal ophthalmia. Ann Trop Paediatr. 2008;28(1):45-48.18318948
Smock KJ, Schmidt RL, Hadlock G, Stoddard G, Grainger DW, Munger MA. Assessment of orally dosed commercial silver nanoparticles on human ex vivo platelet aggregation. Nanotoxicology. 2014;8(3):328-333.23517080
Stepien KM, Morris R, Brown S, Taylor A, and Morgan L. Unintentional silver intoxication following self-medication: an unusual case of corticobasal degeneration. Ann Clin Biochem. 2009;46(pt 6):520-522.19729504
Sterling JP. Silver-resistance, allergy, and blue skin: truth or urban legend? Burns. 2014;40(suppl 1):S19-S23.25418433
Storm-Versloot MN, Vos CG, Ubbink DT, Vermeulen H. Topical silver for preventing wound infection. Cochrane Database Syst Rev. 2010;(3):CD006478.20238345
Tolaymat TM, El Badawy AM, Genaidy A, Scheckel KG, Luxton TP, Suidan M. An evidence-based environmental perspective of manufactured silver nanoparticle in syntheses and applications: A systematic review and critical appraisal of peer-reviewed scientific papers. Sci Total Environ. 2010;408(5):999-1006.19945151

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.